Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Retina > Endophthalmitis rates drop as vitrectomy use declines in eye surgery over 20 years
  • Retina

Endophthalmitis rates drop as vitrectomy use declines in eye surgery over 20 years

Kelsey Moroz

The rate of endophthalmitis after intraocular procedures has significantly decreased over the past 20 years, according to a study, which also noted there has been a notable decline in the use of prompt vitrectomy as the primary treatment for this condition.

The study analyzed data from over 5.8 million intraocular procedures, including surgeries for cataract removal, glaucoma, and retinal conditions. Of the more than 2.1 million patients included in the study, 4305 cases of endophthalmitis were identified, resulting in an overall infection rate of 0.07%. The annual rate of endophthalmitis fell from 0.20% in 2000 to 0.05% in 2022.

The findings also revealed a decrease in the use of prompt vitrectomy as the primary treatment for endophthalmitis. While nearly half of the cases in 2003 were treated with vitrectomy, by 2021, this approach was used in only 11.6% of cases.

Reference
VanderBeek BL, Chen Y, Tomaiuolo M, et al. Endophthalmitis Rates and Types of Treatments After Intraocular Procedures. JAMA Ophthalmol. Published online August 01, 2024. doi:10.1001/jamaophthalmol.2024.2749

Share

Related Content

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

  • Retina

Aflibercept 8 mg demonstrates favorable safety profile in large nAMD cohort

  • Retina

Aflibercept 8 mg shows modest benefits in difficult-to-treat nAMD cases

  • Retina

AXPAXLI meets superiority endpoint in SOL-1 Phase 3 wet AMD trial

  • Diabetic Macular Edema

Hawaiian Eye Meeting update: TKI therapy may reduce treatment burden in DME and wet AMD

  • Retina

Metformin linked to lower incidence of intermediate AMD in patients with diabetes

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon